Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Fifth Disease | Research article

Varicella zoster and fever rash surveillance in Lao People’s Democratic Republic

Authors: Phonethipsavanh Nouanthong, Judith M. Hübschen, Somxay Billamay, Sodaly Mongkhoune, Keooudomphone Vilivong, Vilaysone Khounvisith, Regina Sinner, Marc Grandadam, Darouny Phonekeo, Antony P. Black, Claude P. Muller

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

In Lao PDR, the epidemiology of varicella infection is uncertain, since it is not a notifiable disease and VZV outbreaks are rarely reported as fever/rash (F/R) diseases.

Methods

We estimated the seroprevalence of VZV (IgG ELISA) in different age cohorts (9 months to 46 years; N = 3139) and investigated VZV and 6 other viruses in patients during F/R outbreaks and in an ad hoc sentinel site in the context of the national reporting system (IgM ELISA, PCR).

Results

At least 80% of the sampled population had evidence of VZV infection before the age of 15. The largest increase in seroprevalence occurred between the age groups 1 to 5 and 6 to 7 year-olds. A VZV outbreak (clade 2) also occurred in this age group mostly during the first year of primary school (median age 6 years, interquartile range 4.0–7.5). During a dengue outbreak, 6% had varicella. At our F/R sentinel site, 14% of children with viral etiology were laboratory diagnosed as varicella and among others, a sizeable number of measles (N = 12) and rubella cases (N = 25) was detected compared to those reported for the whole country (N = 56 and 45), highlighting nationwide a large challenge of underreporting or misdiagnosis of these notifiable diseases because of lack of diagnostic laboratory capacity.

Conclusion

We recommend strengthening the clinical and laboratory diagnosis of VZV, measles and rubella, the surveillance and reporting of notifiable F/R diseases by retraining of healthcare workers and by setting up sentinel sites and enhancing laboratory capacity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kang JH. Febrile illness with skin rashes. Infect Chemother. 2015;47(3):155–66.CrossRef Kang JH. Febrile illness with skin rashes. Infect Chemother. 2015;47(3):155–66.CrossRef
2.
go back to reference Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26(4):728–43.CrossRef Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26(4):728–43.CrossRef
3.
go back to reference Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14(Suppl 2):30–4.PubMed Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14(Suppl 2):30–4.PubMed
4.
go back to reference Kositanont U, Wasi C, Oonsombat P, Suvatte V, Thongcharoen P. Susceptibility to varicella-zoster virus in Thai children and young adults. Southeast Asian J Trop Med Public Health. 1985;16(3):414–20.PubMed Kositanont U, Wasi C, Oonsombat P, Suvatte V, Thongcharoen P. Susceptibility to varicella-zoster virus in Thai children and young adults. Southeast Asian J Trop Med Public Health. 1985;16(3):414–20.PubMed
5.
go back to reference Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Tropical Med Int Health. 1998;3(11):886–90.CrossRef Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Tropical Med Int Health. 1998;3(11):886–90.CrossRef
6.
go back to reference Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000;31(4):646–9.PubMed Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000;31(4):646–9.PubMed
7.
go back to reference Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr. 2000;37(7):714–9.PubMed Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr. 2000;37(7):714–9.PubMed
8.
go back to reference Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, et al. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci. 2007;61(3):128–34.CrossRef Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, et al. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci. 2007;61(3):128–34.CrossRef
9.
go back to reference Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005;8(3):209–22.CrossRef Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005;8(3):209–22.CrossRef
10.
go back to reference Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19–20):2500–7.CrossRef Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19–20):2500–7.CrossRef
11.
go back to reference Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15:533.CrossRef Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15:533.CrossRef
12.
go back to reference Sengkeopraseuth B, Bounma K, Siamong C, Datta S, Khamphaphongphane B, Vongphachanh P, et al. Hidden varicella outbreak, Luang Prabang Province, the Lao People’s Democratic Republic, December 2014 to January 2015. Western Pac Surveill Response J. 2016;7(1):1–5.CrossRef Sengkeopraseuth B, Bounma K, Siamong C, Datta S, Khamphaphongphane B, Vongphachanh P, et al. Hidden varicella outbreak, Luang Prabang Province, the Lao People’s Democratic Republic, December 2014 to January 2015. Western Pac Surveill Response J. 2016;7(1):1–5.CrossRef
13.
go back to reference Inoue H, Motani-Saitoh H, Sakurada K, Ikegaya H, Yajima D, Hayakawa M, et al. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1. J Med Virol. 2010;82(2):345–9.CrossRef Inoue H, Motani-Saitoh H, Sakurada K, Ikegaya H, Yajima D, Hayakawa M, et al. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1. J Med Virol. 2010;82(2):345–9.CrossRef
14.
go back to reference Nanthavong N, Black AP, Nouanthong P, Souvannaso C, Vilivong K, Muller CP, et al. Diphtheria in Lao PDR: insufficient coverage or ineffective vaccine? PLoS One. 2015;10(4):e0121749.CrossRef Nanthavong N, Black AP, Nouanthong P, Souvannaso C, Vilivong K, Muller CP, et al. Diphtheria in Lao PDR: insufficient coverage or ineffective vaccine? PLoS One. 2015;10(4):e0121749.CrossRef
15.
go back to reference Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol. 1992;66(5):3206–9.PubMedPubMedCentral Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol. 1992;66(5):3206–9.PubMedPubMedCentral
16.
go back to reference De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18(1):217–45.CrossRef De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18(1):217–45.CrossRef
17.
go back to reference Zhu Z, Xu W, Abernathy ES, Chen MH, Zheng Q, Wang T, et al. Comparison of four methods using throat swabs to confirm rubella virus infection. J Clin Microbiol. 2007;45(9):2847–52.CrossRef Zhu Z, Xu W, Abernathy ES, Chen MH, Zheng Q, Wang T, et al. Comparison of four methods using throat swabs to confirm rubella virus infection. J Clin Microbiol. 2007;45(9):2847–52.CrossRef
18.
go back to reference Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol. 2010;91(Pt 4):821–8.CrossRef Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol. 2010;91(Pt 4):821–8.CrossRef
19.
go back to reference Rubella virus nomenclature update: 2013. Wkly Epidemiol Rec 2013; 88(32):337–343. Rubella virus nomenclature update: 2013. Wkly Epidemiol Rec 2013; 88(32):337–343.
20.
go back to reference Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4.CrossRef Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4.CrossRef
21.
go back to reference Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hubschen JM, Muller CP. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR. PLoS One. 2015;10(4):e0123647.CrossRef Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hubschen JM, Muller CP. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR. PLoS One. 2015;10(4):e0123647.CrossRef
22.
go back to reference Gorny AW, Mittal C, Saw S, Venkatachalam I, Fisher DA, Tambyah PA. Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data. BMC Res Notes. 2015;8:664.CrossRef Gorny AW, Mittal C, Saw S, Venkatachalam I, Fisher DA, Tambyah PA. Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data. BMC Res Notes. 2015;8:664.CrossRef
24.
go back to reference Lenaerts L, De Clercq E, Naesens L. Clinical features and treatment of adenovirus infections. Rev Med Virol. 2008;18(6):357–74.CrossRef Lenaerts L, De Clercq E, Naesens L. Clinical features and treatment of adenovirus infections. Rev Med Virol. 2008;18(6):357–74.CrossRef
25.
go back to reference Paticheep S, Kongsaengdao S. Viral infection of central nervous system in children: one year prospective study. J Med Assoc Thail. 2011;94(Suppl 7):S24–31. Paticheep S, Kongsaengdao S. Viral infection of central nervous system in children: one year prospective study. J Med Assoc Thail. 2011;94(Suppl 7):S24–31.
26.
go back to reference Wananukul S, Nopponpunth V, Poovorawan Y. Human herpesvirus infection in children with fever and maculopapular rash. Asian Pac J Allergy Immunol. 2003;21(4):217–21.PubMed Wananukul S, Nopponpunth V, Poovorawan Y. Human herpesvirus infection in children with fever and maculopapular rash. Asian Pac J Allergy Immunol. 2003;21(4):217–21.PubMed
Metadata
Title
Varicella zoster and fever rash surveillance in Lao People’s Democratic Republic
Authors
Phonethipsavanh Nouanthong
Judith M. Hübschen
Somxay Billamay
Sodaly Mongkhoune
Keooudomphone Vilivong
Vilaysone Khounvisith
Regina Sinner
Marc Grandadam
Darouny Phonekeo
Antony P. Black
Claude P. Muller
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3990-7

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue